01 August 2023>: Articles
Unexpected Acute Hyperglycemia Following Pre-Surgical Discontinuation of SGLT2 Inhibitors in a Type 1 Diabetic Patient
Unusual or unexpected effect of treatment
Yuki Tsujimoto A , Yosuke Nagai A* , Rimei Nishimura ADOI: 10.12659/AJCR.940190
Am J Case Rep 2023; 24:e940190
Figure 2. (A–F) Intermittently scanned continuous glucose monitoring data of interest. Orange squares indicate the meals taken, yellow green squares indicate the units of bolus insulin injected, and dark green squares indicate the units of basal insulin injected. Sensor Glucose level are mean±SD. The data for day 2 were partially missing due to the need to replace the isCGM; the data from day 7 (only available until 9: 00) to day 8 are missing because the CGM had to be removed during surgery (A) day 8, postoperative day 1; (B) day 9, postoperative day 2; (C) day 10, postoperative day 3; (D) day11, re-initiation of SGLT2 inhibitor therapy 1 day after discontinuation of SGLT2 inhibitor therapy; (E) day 12, 1 day after re-initiation of SGLT2 inhibitor therapy; and (F) day 16, 1 day before discharge.